Mainz Biomed B.V. (MYNZ): Price and Financial Metrics
MYNZ Price/Volume Stats
| Current price | $4.27 | 52-week high | $45.20 |
| Prev. close | $4.25 | 52-week low | $3.65 |
| Day low | $3.90 | Volume | 241,500 |
| Day high | $4.35 | Avg. volume | 219,765 |
| 50-day MA | $5.43 | Dividend yield | N/A |
| 200-day MA | $10.44 | Market Cap | 8.54M |
MYNZ Stock Price Chart Interactive Chart >
Mainz Biomed B.V. (MYNZ) Company Bio
Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic tests for clinical diagnostics in the area of human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, an early-stage molecular lateral-flow test; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.
MYNZ Price Returns
| 1-mo | -24.56% |
| 3-mo | -5.95% |
| 6-mo | -56.78% |
| 1-year | -89.43% |
| 3-year | -99.27% |
| 5-year | N/A |
| YTD | -1.16% |
| 2024 | -90.69% |
| 2023 | -83.66% |
| 2022 | -31.67% |
| 2021 | N/A |
| 2020 | N/A |
Loading social stream, please wait...